Scott Kellen

Chief Financial Officer

CFO

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	DiaMedica Therapeutics Inc. (DMAC)	Chief Financial Officer and Secretary	$408,500	—	—	$619,650	$183,920	$17,450	$1,229,520
2024	DiaMedica Therapeutics Inc. (DMAC)	Chief Financial Officer and Secretary	$374,250	—	—	$274,521	$147,934	$17,250	$813,955
2023	DiaMedica Therapeutics Inc. (DMAC)	Chief Financial Officer and Secretary	$352,750	—	—	$146,790	$116,025	$16,650	$632,215
2022	DiaMedica Therapeutics Inc. (DMAC)	Chief Financial Officer and Secretary	$329,392	—	—	$116,549	$101,983	$15,650	$563,574
2021	DiaMedica Therapeutics Inc. (DMAC)	Chief Financial Officer and Secretary	$286,211	—	—	$154,999	$90,460	$15,050	$546,720
2020	DiaMedica Therapeutics Inc. (DMAC)	Chief Financial Officer and Secretary	$276,075	—	—	$119,140	$79,238	$14,850	$489,303
2019	DiaMedica Therapeutics Inc. (DMAC)	Chief Financial Officer and Secretary	$262,500	—	—	$336,557	$64,800	$13,950	$677,807
2018	DiaMedica Therapeutics Inc. (DMAC)	Chief Financial Officer and Secretary	$200,833	—	—	$361,957	$70,200	$9,931	$642,921

Earnings-call appearances

DiaMedica Therapeutics Inc. Q1 FY2026 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2026-05-07
DiaMedica Therapeutics Inc. Q4 FY2025 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2026-03-31
DiaMedica Therapeutics Inc. Q3 FY2025 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2025-11-12
DiaMedica Therapeutics Inc. Q2 FY2025 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2025-08-12
DiaMedica Therapeutics Inc. Q1 FY2025 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2025-05-13
DiaMedica Therapeutics Inc. Q4 FY2024 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2025-03-17
DiaMedica Therapeutics Inc. Q3 FY2024 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2024-11-13
DiaMedica Therapeutics Inc. Q2 FY2024 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2024-08-07
DiaMedica Therapeutics Inc. Q1 FY2024 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2024-05-08
DiaMedica Therapeutics Inc. Q4 FY2023 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2024-03-19
DiaMedica Therapeutics Inc. Q3 FY2023 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2023-11-13
DiaMedica Therapeutics Inc. Q2 FY2023 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2023-08-14
DiaMedica Therapeutics Inc. Q1 FY2023 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2023-05-15
DiaMedica Therapeutics Inc. Q4 FY2022 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2023-03-28
DiaMedica Therapeutics Inc. Q2 FY2022 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2022-08-10
DiaMedica Therapeutics Inc. Q4 FY2021 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2022-03-14
DiaMedica Therapeutics Inc. Q3 FY2021 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2021-11-10
DiaMedica Therapeutics Inc. Q2 FY2021 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2021-08-11
DiaMedica Therapeutics Inc. Q1 FY2021 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2021-05-05
DiaMedica Therapeutics Inc. Q4 FY2020 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2021-03-10
DiaMedica Therapeutics Inc. Q3 FY2020 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2020-11-04
DiaMedica Therapeutics Inc. Q2 FY2020 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2020-08-05
DiaMedica Therapeutics Inc. Q1 FY2020 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2020-05-13